Cardioprotective Effect of RIPC in Patients Undergoing TAVI

NCT02283398 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
NETWORK
Sponsor class

Stopped administrative issues

Conditions

Interventions

Sponsor

Institut für Pharmakologie und Präventive Medizin